Plaque disruption and thrombosis. Potential role of inflammation and infection.
Considerable data from in vitro and in vivo studies of vascular biology, together with indirect evidence from clinical trials of lipid-lowering or modifying and lifestyle or risk factor modifying interventions, provide strong support for the concept that disruption of atherosclerotic plaque and subsequent thrombosis is a key precipitant of potentially lethal, acute coronary syndromes. Certain characteristics of plaques, including the size and composition of the lipid core, the structure and composition of the fibrous cap, and the presence of a local inflammatory process, predispose the plaque to disruption. Stresses resulting from biomechanical and hemodynamic forces acting on plaques may then trigger disruption, releasing the thrombogenic contents of the lipid core. Alterations in endothelial function may also contribute to vulnerability of plaque rupture and thrombosis. Therefore, interventions aimed at decreasing plaque vulnerability to disruption--all based on the concept of plaque stabilization--may reduce the risk of acute coronary syndromes. Although not yet rigorously validated in humans, plaque stabilization may prove to be an important clinical strategy for preventing the lethal consequences of coronary atherosclerosis.
Shah
P K
PK
Atherosclerosis Research Center, Burn and Allen Research Institute, Los Angeles, California, USA. Shahp@cshs.org
D017209:Apoptosis; D001696:Biomechanical Phenomena; D003324:Coronary Artery Disease / Q000473:pathology / Q000503:physiopathology*; D003328:Coronary Thrombosis / Q000473:pathology / Q000503:physiopathology*; D006439:Hemodynamics; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D008666:Metalloendopeptidases / Q000032:analysis; D012422:Rupture, Spontaneous; D013314:Stress, Mechanical
D008666:Metalloendopeptidases